SCHEMBL31728913

SCHEMBL31728913

C[C@@H](Oc1cnc(-c2ccc(F)c(Cl)c2F)c2ncncc12)c1nc[nH]n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728571 0.83 MET (0.35) MET
SCHEMBL31729165 0.83 MET (0.35) MET
SCHEMBL31729296 0.74 — —
SCHEMBL31728084 0.72 MET (0.35) MET
SCHEMBL31728182 0.72 MET (0.35) MET
SCHEMBL31729231 0.68 EPHA2 (0.31) —
SCHEMBL31729160 0.67 MET (0.33) MET
SCHEMBL31728923 0.64 POLB (0.36) MET
SCHEMBL31727836 0.62 CYP1A2 (0.35) —
SCHEMBL31727874 0.56 CLK1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback